RxDoctor Payments DataLook up a doctor →

Jelena Kunovac

Psychiatry · Las Vegas, NVNPI 1851402259

Payments from drug & device makers

$12,391,285in general payments, 2019–2025

Across 2,262 payments — averaging $5478.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$3M
  • AbbVie$2.8M
  • Sage Therapeutics, LLC$1.4M
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$1.3M
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$633K
  • Bioxcel Therapeutics, Inc.$481K
  • plus $2.8M from 34 others
$5,201in research payments, 2019–2025

Across 26 payments — averaging $200.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Supernus Pharmaceuticals, Inc.$2K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$1K
  • Corcept Therapeutics$1K
  • Eli Lilly$224

What the payments were for

  • Consulting fees$225,37218%
  • Speaking & faculty fees$864,12170%
  • Travel & lodging$131,39911%
  • Food & beverage$20,0702%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Teva Pharmaceuticals USA, Inc.125$3,040,198
AbbVie(2 entities)276$2,776,312
Sage Therapeutics, LLC173$1,350,042
Otsuka Pharmaceutical Development & Commercialization, Inc.15$1,282,907
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)254$632,761
Bioxcel Therapeutics, Inc.14$480,531
Alkermes, Inc.356$475,717
Vanda Pharmaceuticals Inc.56$400,764
Otsuka America Pharmaceutical, Inc.294$313,104
Sunovion Pharmaceuticals Inc.173$254,101
Supernus Pharmaceuticals, Inc.56$176,639
Merck11$175,733
E.r. Squibb & Sons, L.L.C.108$154,963
Boehringer Ingelheim14$107,751
Axsome Therapeutics, Inc.77$95,938
Corcept Therapeutics32$89,154
Acadia Pharmaceuticals Inc34$74,669
Jazz Pharmaceuticals Inc.9$65,479
Biohaven Pharmaceutical Holding Company Ltd.35$53,159
Janssen Research & Development, LLC3$51,027
Biogen3$48,361
GW Research Limited17$45,188
Biohaven Pharmaceuticals, Inc.15$44,327
H. Lundbeck A S3$30,448
Indivior Inc.15$28,486
Takeda Pharmaceuticals U.S.A., Inc.2$28,421
Johnson & Johnson27$20,515
Bayer18$19,944
F. Hoffmann-la Roche AG8$18,850
Avanir Pharmaceuticals, Inc.2$16,813
Novo Nordisk AS9$12,153
Neurocrine Biosciences, Inc.1$8,000
Livanova USA, Inc.3$6,276
Sumitomo Pharma America, Inc.4$5,731
Tolmar, Inc.3$2,952
Boehringer Ingelheim Canada Ltd.ltee13$2,878
Boehringer Ingelheim Pharma GmbH & Co.kg1$752
Lundbeck LLC1$109
Tris Pharma Inc1$107
Boston Scientific1$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,391,285 in reported general payments places this provider in the 95th percentile of 243 psychiatry providers in Nevada.

See all psychiatry providers in Nevada →

Other psychiatry in Las Vegas

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →